Impact of new drugs and biologics on colorectal cancer treatment and costs. - Wikidata - wikimedia - TriplyDB

Impact of new drugs and biologics on colorectal cancer treatment and costs.

Impact of new drugs and biologics on colorectal cancer treatment and costs.

http://www.wikidata.org/entity/Q34974196

about

Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan Ultrasound-mediated gastrointestinal drug delivery.Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece.The cost of cancer-related physician services to Medicare.The high cost of cancer drugs and what we can do about it.Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study Variation of Cost among Anti-cancer Drugs Available in Indian Market.Systematic review and quality assessment of cost-effectiveness analysis of pharmaceutical therapies for advanced colorectal cancer.

P2860

Q24658652-7EB743AE-EE69-4FF6-9FDA-F7E5447E647B Q27325548-158A3136-DE1C-4CFF-91EE-A22DFF0B30B9 Q34361406-0BC70B08-9647-4D95-957C-D14DCDFE043E Q35652690-D7AAA132-9D3B-4D04-A566-AD6CBC0571AD Q36512856-79C9312A-FD6A-481F-A043-9CDE09514D8F Q36551145-04DBF30B-3FD5-4147-BE57-7F0CE4E36B16 Q37007189-C74B2FF4-4413-4C66-AA9A-460B0F933145 Q37543021-C1B13919-BABE-40BE-AA19-012C4F63A726 Q38095230-CBB2CEE7-72ED-4D64-9F68-5AA1F31D3A9B

P2860

Impact of new drugs and biologics on colorectal cancer treatment and costs.

http://www.wikidata.org/entity/Q34974196

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@ast

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@en

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@nl

type

label

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@ast

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@en

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@nl

prefLabel

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@ast

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@en

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@nl

P1433

Q34974196-2A93A71B-2102-405E-8C52-C670E2A4AC03

P1476

Q34974196-0C97294A-39BC-4C3F-BE8F-D29B1BF9CF00

P2093

Q34974196-243E0BB1-FC00-4CEC-AAE0-6FC54FA9A80C

Q34974196-2C42DB68-504E-43C4-8BCA-8496C47129EE

Q34974196-2D5674D7-3562-448C-AC25-BC95D454EA46

Q34974196-80840F5F-04B6-4E8A-A0E8-19F5715FF17D

Q34974196-E8A8336C-F2BC-4F31-A4C3-ECF8C2A96F79

P2860

Q34974196-22F2FE39-C932-4E7F-AA2E-1EA36852675B

Q34974196-2F81F0A0-907B-4BCE-9EBE-D4D6BAA6AAB9

Q34974196-3483DB00-E3D7-49A3-9237-D617F447FCCE

Q34974196-737174DD-B575-4B97-92C5-177FFEFF64F1

Q34974196-87F3CA9A-79A4-4994-B4AB-C912D6F6C48E

Q34974196-947FE088-1E88-4B35-9586-46BEE9FADB6D

Q34974196-9EB1E165-B08A-4B29-A0D8-82A993559978

Q34974196-A63F1714-0C10-43AB-9065-DF6FDC0F6724

Q34974196-A774863A-4F77-4BA7-9DF2-B75F4DBBB1E6

Q34974196-B461F86A-3D13-4FA8-A0B7-97324E682828

P304

Q34974196-66DCFF93-E9A5-4644-96A1-31B2CC52550B

P31

Q34974196-7EF163D2-A31F-4A8A-B97B-A37A4378379D

P356

Q34974196-32CB7CE7-61DD-499C-8AF1-B0BAB2AF0B18

P407

Q34974196-FE87C8EC-E457-4540-86E5-803C4562A049

P433

Q34974196-2503A9F9-6453-4CA1-B51A-8B4CDAF45565

P478

Q34974196-E5F30AFD-45C4-454F-B79D-4E7C289A6447

P577

Q34974196-A852EF71-BD5C-489A-B1EA-21FAD25FEF7A

P698

Q34974196-D01E3AF0-AF4B-4400-A9BA-5C299EE167C9

P921

Q34974196-399CD7F3-6EBA-48D2-8357-2D3B0C15D94B

P932

Q34974196-95C10F81-D5F2-43D9-9FC4-5E1D010632E9

P356

JOP.2011.000302

P1433

Journal of Oncology Practice

P1476

Impact of new drugs and biologics on colorectal cancer treatment and costs.

@en

P2093

Holly Van Houten

http://www.w3.org/2001/XMLSchema#string

Jeffrey S McCullough

http://www.w3.org/2001/XMLSchema#string

Mustaqeem A Siddiqui

http://www.w3.org/2001/XMLSchema#string

Nilay D Shah

http://www.w3.org/2001/XMLSchema#string

Pinar Karaca-Mandic

http://www.w3.org/2001/XMLSchema#string

P2860

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

The price tag on progress--chemotherapy for colorectal cancer.

Evaluation of trends in the cost of initial cancer treatment

Cost of cancer care: issues and implications.

The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003.

Impact of specialty drugs on the use of other medical services.

Second-line and third-line chemotherapy for lung cancer: use and cost.

P304

e30s-7s

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JOP.2011.000302

http://www.w3.org/2001/XMLSchema#string

P407

P433

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21886509

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3092464

http://www.w3.org/2001/XMLSchema#string